Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2022

View Archived Issues

MR-2088: a first-reported ULK1 inhibitor for RAS-driven cancers

A novel series of pyrralothiazole-based dual TLR7/8 antagonists for the potential treatment of lupus

Genentech degrader-antibody conjugates targeting BRD4 show anticancer activity

Emory University patents thymidylate synthase inhibitors

Massachusetts Institute of Technology divulges new c-Myb inhibitors

Korean researchers identify new NADPH oxidase inhibitors

Kezar Life Sciences presents new protein secretion inhibitors

Roche discloses new MAGL inhibitors

Bat3 as potential therapeutic target and endogenous regulator of DC function

Discovery of vilazodone-donepezil chimeras for the treatment of AD with comorbid depression

NeonMind's preclinical data show efficacy of psilocybin in reducing weight gain in obese animals

Phylex mRNA vaccine elicits protection against SARS-CoV-2 Delta variant in transgenic mouse model

PY-265 targets MARCO and enhances antitumoral immune response

Nonhormonal male contraceptive prevents pregnancy in partners

Cyclica and Arctoris expand partnership to progress drug discovery in Alzheimer's disease

INRS advances vaccine for melioidosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...